Oncology Oncology Promotion in 2023 [Webinar] Sign up to listen to industry experts speak about the 4 success strategies for oncology promotion .site-header-content h2 { color: white; } form { width: 100%; } label { text-align: left; color: #738a94; font-size: 15px; font-family: Poppins, sans-serif;
Oncology The 2023 Oncology Promotion Playbook As oncologists get busier and less available, how do life sciences organizations optimize oncologist attention and create impactful omnichannel messages? How do companies better understand and use digital influencers to enhance their messaging?
Oncology Oncology Commercial Leadership: Top 5 Pharma Manufacturers Success strategies of the leading oncology manufacturer repsMany factors contribute to the success of any oncology therapy, beginning with efficacy. Yet, widespread uptake relies on physician prescribing power—and oncologists’ willingness to wield
Oncology Top 10 Pharma Websites Where Oncologists Spend Time The digital landscape is incredibly diverse and saturated. In order to effectively reach your target customers and have a meaningful impact, you need to understand your customer preferences. Our omnichannel intelligence tool, PERxCEPT,
Conferences ASH'22: Showcasing cutting-edge approaches for treating Acute Myeloid Leukemia Abstracts for the American Society of Hematology’s (ASH) 64th Annual Meeting were released on November 3rd, in anticipation of opening remarks beginning in New Orleans on December 10. As the healthcare world
Conferences Novel approaches for treating Multiple Myeloma will be featured in ASH 2022 Abstracts for the American Society of Hematology’s (ASH) 64th Annual Meeting were released on November 3rd, in anticipation of opening remarks beginning in New Orleans on December 10. As the healthcare world
Oncology The Three Keys to Memorable Oncology Promotional Messaging Today’s oncologists are besieged with information. A steady stream of emails, texts, and other electronic notifications compete with an avalanche of scientific papers and journals demanding to be read—all wedged between
Oncology Oncologists share exclusive insights on the developments in breast cancer therapies in the past year Breast Cancer Awareness Month (BCAM) is a time to celebrate the strength of breast cancer survivors and to champion all of those who are fighting to eradicate this group of diseases. At ZoomRx,
Oncology Going Beyond Impressions: Learnings from Digitally Active Oncology Brands Here, we combine PERxCEPT's digital tracking technology with our agile market research techniques to reveal the true impact of the most widespread digital campaigns on HCP perceptions and real-world behavior.
Oncology Cancer Moonshot: Oncologists express optimism about cutting cancer-related deaths Oncologists on the ZoomRx panel express their thoughts on the Cancer Moonshot initiative.
Oncology The Evolution of Medical Conferences: The New Normal is Here As we move back to a place where in-person conferences are possible, how should these conferences be structured in terms of in-person vs. virtual engagement to achieve success?
PERxCEPT The Top 10 Most Digitally Active Oncology Brands in Q2'22 ZoomRx has ranked the leading oncology brands by their Q2’22 digital activity by collecting banner ad impressions across the entire digital landscape, with the help of ZoomRx's new omnichannel intelligence tool, PERxCEPT.
Oncology 2022 ASCO Annual Meeting: Major Scientific Progress Moves the Field of Oncology Beyond COVID A strong line up of potentially practice-changing presentations generated a great deal of excitement among attendees at ASCO#2022 – both those in person at the McCormick Convention Center and those attending virtually. Based
Conferences Recent Advances in Multiple Myeloma (ASH 2021) Data that was released during the American Society of Hematology (ASH) 2021 meeting represents significant progress in the field and will have a positive impact on patients’ lives. Below are a few of
Oncology Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach Recent developments across three subtypes of advanced breast cancer – HER2+, TNBC, and HR+/HER2- have generated enthusiasm among oncologists in the United States. While oncologists are stopping short of calling advanced breast cancer
Conferences New Data in Early Settings and the Continued Development of Immunotherapies Captured Attention during ASCO's 2021 Annual Meeting. Among clinical topics, new data in early settings and continued development of immunotherapies stood out to oncologists as areas that can change their practice in the immediate future.
Covid-19 Q3 Earnings Calls Presented a Case for Cautious Optimism Having weathered many challenges in Q2 2020, biopharmaceutical firms, by and large, presented a case for optimism during Q3 2020 earnings calls. However, alongside this optimistic outlook were a number of voices expressing
Conferences ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital.While the virtual format has undoubtedly impacted attendees’ experiences and
Customer Engagement The Benefits of Video-Conferences over Phone Calls for Oncology Sales Interactions During the COVID-19 pandemic, video conferences have proven to drive much better results compared to phone calls for oncology sales interactions.
Oncology Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers.Oncologist-patient relationships are based
Customer Engagement Exploring Factors Influencing Individualized Treatment: Breast Cancer Oncologists often develop individualized treatment plans to ensure patients are receiving care tailored to their situation. Here are factors influencing their decisions.
Conferences ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at
Conferences ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and
Covid-19 Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of
Conferences ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to
![Oncology Promotion in 2023 [Webinar]](/content/images/size/w600/2023/03/ranking-abstract.jpg)
